Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries 23Andme Holding Co. (NQ: ME ) 0.3234 +0.0131 (+4.22%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 7,758,533 Open 0.3130 Bid (Size) 0.3206 (1) Ask (Size) 0.3249 (1) Prev. Close 0.3103 Today's Range 0.3020 - 0.3262 52wk Range 0.3020 - 1.250 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News ME Stock Earnings: 23andMe Holding Beats EPS, Misses Revenue for Q1 2025 August 08, 2024 ME stock results show that 23andMe Holding beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025. Via InvestorPlace 23andMe Reports First Quarter Fiscal 2025 Financial Results August 08, 2024 From 23andMe, Inc. Via GlobeNewswire Performance YTD -64.40% -64.40% 1 Month -27.83% -27.83% 3 Month -40.55% -40.55% 6 Month -49.66% -49.66% 1 Year -70.86% -70.86% More News Read More ME Stock Alert: CEO Anne Wojcicki Enters $200 Million Buyout Offer for 23andMe August 02, 2024 Via InvestorPlace 23andMe Special Committee responds to CEO’s take-private proposal August 02, 2024 From 23andMe, Inc. Via GlobeNewswire Looking Into 23andMe Holding's Recent Short Interest June 12, 2024 Via Benzinga 23andMe Announces CEO’s Take-Private Proposal August 01, 2024 From 23andMe, Inc. Via GlobeNewswire 23andMe to Report Q1 FY2025 Financial Results July 25, 2024 From 23andMe, Inc. Via GlobeNewswire Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance Research July 25, 2024 From 23andMe, Inc. Via GlobeNewswire The 3 Best Personalized Nutrition Stocks to Buy Now July 24, 2024 Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence 23ANDME INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates 23andMe Holding Co. - ME July 19, 2024 From Kahn Swick & Foti, LLC Via Business Wire 3 High-Dividend Stocks to Buy if You Are Seeking Consistent Payouts July 11, 2024 Via InvestorPlace 23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel June 28, 2024 From 23andMe, Inc. Via GlobeNewswire 3 Ultra-High-Yield Dividend Stocks to Buy Hand Over Fist Right This Instant June 27, 2024 Via The Motley Fool 3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition June 11, 2024 Via InvestorPlace 23andMe Launches New Genetic Report on Bipolar Disorder June 05, 2024 From 23andMe, Inc. Via GlobeNewswire Why 23andMe Stock Tumbled 10% on Tuesday June 04, 2024 Via The Motley Fool 23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black Community June 04, 2024 From 23andMe, Inc. Via GlobeNewswire 23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting June 03, 2024 From 23andMe, Inc. Via GlobeNewswire Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history May 29, 2024 From 23andMe, Inc. Via GlobeNewswire ME Stock Earnings: 23andMe Holding Beats EPS, Beats Revenue for Q4 2024 May 23, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session May 23, 2024 Via Benzinga 23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results May 23, 2024 From 23andMe, Inc. Via GlobeNewswire Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals May 14, 2024 From 23andMe, Inc. Via GlobeNewswire 23andMe to Report Q4 and Full Year FY2024 Financial Results May 09, 2024 From 23andMe, Inc. Via GlobeNewswire Potter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach Case April 30, 2024 From Potter Handy LLP Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.